Skip to main content
Clinical Trials/NCT02912065
NCT02912065CompletedNot Applicable

Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay: A Retrospective Assessment

Société des Produits Nestlé (SPN)1 site in 1 country13 target enrollmentStarted: January 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
13
Locations
1
Primary Endpoint
Feeding tolerance after switching to Peptide based formula

Study Overview

Brief Summary

A retrospective chart review to assess feeding tolerance in children who had been switched from an intact protein formula to a Peptide based formula due to feeding intolerance in a pediatric facility for the developmentally delayed.

Detailed Description

Medical records of pediatric patients with enteral feeding intolerance on standard polymeric formulas that were switched to a peptide based formula will be retrospectively analyzed. Data will be collected on caloric intake, ability to meet enteral nutrition goals, incidence of intolerance, and the use of medications to control gastrointestinal symptoms.

Study Design

Study Type
Observational
Time Perspective
Retrospective

Eligibility Criteria

Ages
13 Months to 17 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •13 months to < 18 years of age on admission to facility
  • •Required enteral nutrition to meet 90% or more of their energy needs prior to switch to a Peptide based formula
  • •Received enteral nutrition with an intact protein formula for a minimum of two weeks prior to a switch to a Peptide based formula
  • •Have documentation of intolerance to an intact protein formula, followed by a switch in formula received to a Peptide based formula
  • •Have documentation of an assessment of feeding tolerance following the switch to a Peptide based formula
  • •Formulas received must be indicated for use in children or adults (not infant formulas).

Exclusion Criteria

  • •Recent abdominal surgery, change in tube position/placement (within past 30 days)
  • •Cow's milk protein allergy
  • •Any current infections including upper respiratory, viral, gastroenteritis, wound infection.

Outcomes

Primary Outcomes

Feeding tolerance after switching to Peptide based formula

Time Frame: up to 30 days post formula switch

Categorized as no change, tolerance improved, tolerance worsened.

Secondary Outcomes

  • Intake of target feeding volume(up to 30 days post formula switch)
  • Feeding intolerance parameter(s) identified before switch to Peptide based formula and feeding tolerance parameter(s) improved by switch.(up to 30 days post formula switch)

Investigators

Sponsor
Société des Produits Nestlé (SPN)
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials